Lenvatinib Combined With TACE and Camrelizumab in Conversion Resection for Advanced Hepatocellular Carcinoma (LEN-TAC Study)
Clinical trial NCT05738616 · RECRUITING
Trial details
- NCT number
- NCT05738616
- Sponsor
- Wen Tianfu
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-10
- Primary completion
- 2027-05-01
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.